The global dermatology treatment devices market is expected to reach US$ 8,800.07 million in by 2027 from US$ 5,320.73 million in 2019;. The market it is estimated to grow with at a CAGR of 6.7% from 2020 to 2027.

Factors such as rising prevalence of skin issues and technological advancements in dermatology treatment devices drive the growth of the market. However, the risk of undesirable side effects associated with the use of dermatology treatment devices hinders the market growth.Factors such as rising prevalence of skin issues and technological advancements in dermatology treatment devices are expected to boost the growth of the market. However, the risk of undesirable side effects associated with the use of dermatology treatment devices is likely to hinder the market growth.

Dermatology is a medical field engaged in the diagnosis, prevention, and treatment of various diseases related to nail-s, skin-, and hair-related diseases, such as pigmentation, acne, wrinkles, and psoriasis. The devices are used to treat skin conditions and are also employed to prevent certain skin disorders. Major devices used for derma treatments are lasers, light therapy devices, cryotherapy devices, microdermabrasion devices, and energy-based therapies devices, and micro needling, among others.

Continuous research and development studies are being carried out worldwide to gain a better understanding on skin-related medical conditions. Companies are investing in the development of new and innovative medical devices to secure good return on investment (ROI). In addition, the approval by regulatory authorities confirms reliability and credibility of the new- age products and medical devices for skin treatment. For instance, in January 2020, 3Derm Systems, Inc., a leader in skin imaging and diagnostics, received two breakthrough device designations from the US Food and Drug Administration (FDA) for 3DermSpot. The product uses artificial intelligence for the autonomous detection of melanoma, basal cell carcinoma, and squamous cell carcinoma.

Lasers have been playing a major role in various dermatology treatment devices, and with leading players have introduceding several innovative products in the market in the recent years. For instance, in September 2016, Alma Lasers introduced a liposuction product named Alma LipoLife 3G that offers optimum safety and proven clinical results. The product encompasses multiple stages in liposuction, fat grafting, and skin tightening. Moreover, in April 2019, Lumenis, an energy-based medical device company, introduced Legand Pro+, a multi-application platform for aesthetic and surgical applications; it is powered by four clinically-proven, complimentary technologies of the company.

Further, an Eeasy access to Internet and beauty blogs, ensuring more efficient reach to target audience, has been a key factor boosting the sales of innovative products. In April 2019, Alma Lasers introduced BeautiFill, a first laser platform generating high-quality autologous fat for face and holistic body contouring procedures. Similarly, in July 2018, Lumenis introduced NuEra tight at the Aesthetic Show, which is a high-power and temperature-controlled RF cellulite and skin laxity treatment for deep and superficial heating. The mounting number of launches of such novel products facilitates the growth of the dermatology treatment market.

Based on On the basis of product, the dermatology treatment devices market was is segmented into lasers, light therapy devices, energy-based therapies devices, microdermabrasion devices, microneedling, and cryotherapy devices. In 2019, the lasers segment accounted for the highest greatest share in the market and is likely to retain its share-based dominancet share owing in the coming years owing to the factors such as increasing adoption of lasers for aesthetic and dermatology issues, rising adoption of laser-based procedures, ease of the treatment, and reliability of the procedure results. In addition, the development of low- cost lasers for home-based uses applications is likely to offers growth opportunitiesy for to the market players operating in the dermatology treatment devices industrymarket.

The COVID-19 pandemic was first reported in December 2019 in Wuhan (China). The impacts of this outbreak are being felt across several markets in the world. The demand for dermatology treatment devices has reduced amid this global crisis due to a significant shift in the focus toward the management, treatment and prevention of COVID-19. The pandemic is continuing to worsen around the world leading to massive disruptions in global supply chains, consumer markets, and economies, and these conditions are also restraining the growth of the dermatology treatment devices market.COVID-19 virus outbreak was first observed in December 2019 in Wuhan (China), and it has spread to ~100 countries across the world, with the World Health Organization (WHO) stating it as a public health emergency. The global impacts of COVID-19 are being felt across several markets.The demand for dermatology treatment devices has reduced as the management and development of treatment for COVID 19 has emerged as an emergency worldwide. The pandemic is continuing to worsen around the world leading to massive disruptions in global supply chains, consumer markets and the economy as a whole, thereby negatively affecting the growth of the dermatology treatment devices.

The Centers for Disease Control and Prevention (CDC), World Health Organization (WHO), European Union (EU), Organization for Economic Co-operation and Development, National Cancer Institute, American Academy of Dermatology Association, Central Intelligence Agency (CIA), and National Health Service (NHS) are a few of the essential prime secondary sources referred to while preparing this report.